Supira Medical
PrivateLast Round
Series E
Mar 26, 2025
Est. Valuation
$420M
Total Funding Raised
$240.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Supira Medical is a medical device company that develops percutaneous ventricular assist devices (pVAD) to provide temporary mechanical support for patients experiencing cardiogenic shock or undergoing high-risk percutaneous coronary interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Supira Medical Comparables
Compare Supira Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magenta Medical | 94% | |
| Procyrion | 88% | |
| Johnson & Johnson | 84% |
Supira Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Mar 26, 2025 | ||||
| Series D | Nov 21, 2023 | ||||
| Series C | Feb 28, 2022 | ||||
| Series B | Feb 25, 2020 | ||||
| Series A | Apr 25, 2018 |
Supira Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shifamed | Series C, Series D, Series B, Series A |
| Cormorant Asset Management | Series A, Series E, Series C, Series D, Series B |
| 415 | Series C, Series B, Series E |
| 415 Capital | Series C, Series D, Series B, Series E |
| Unorthodox Ventures | Series D, Series E |
| Cormorant Capital | Series E |
| The Capital Partnership | Series B, Series E, Series C, Series D, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 38% MoM.
- Apr 8, 2026
D. Keith Grossman appointed to the Board of Directors.
Supira Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Supira Medical's valuation, stock price, and market status.
Is Supira Medical a public or private company?
Supira Medical is a private company.
What is the current stock price of Supira Medical?
Supira Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Supira Medical worth (valuation)?
Valuation information for Supira Medical is not publicly available.
Can I buy Supira Medical stock?
Supira Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Supira Medical's last funding round?
Supira Medical's most recent funding round was Series E on March 26, 2025.
Who are the main investors in Supira Medical?
Key investors in Supira Medical include The Capital Partnership, Novo Holdings, Cormorant Asset Management, Qatar Investment Authority.
Will Supira Medical IPO soon?
No public IPO plans have been announced for Supira Medical.
How can I track Supira Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Supira Medical's secondary market activity and sign up for updates.